Recent

% | $
Quotes you view appear here for quick access.

Exact Sciences Corporation Message Board

  • tradingchampion tradingchampion Mar 4, 2014 1:39 PM Flag

    One must be honest, we actually DO face a "binary event" with this stock.

    By that, I'm referring to the upcoming FDA review that is scheduled take place on March 27, a little over 3 weeks from now. The fact remains, there is so very much potential for this test if endorsed by the FDA, that the company has an uncontested, unrivaled 3 BILLION dollar market opportunity on it's hands. HOWEVER (intentional caps here), IF the FDA rejects Cologuard as a superfluous and ineffectual adjunct to colonoscopy, the stock will likely fall to less than 25% from where it stands today, (or, below $4.00).
    Place your bets ladies and gentlemen. We will have clearly identified a large number of "fools" by April Fools Day, no matter which side the FDA comes down on.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
EXAS
24.42-0.48(-1.93%)3:00 PMEDT